Загрузка...
Targeting SALL4 by entinostat in lung cancer
The overall survival of lung cancer patients remains dismal despite the availability of targeted therapies. Oncofetal protein SALL4 is a novel cancer target. We herein report that SALL4 was aberrantly expressed in a subset of lung cancer patients with poor survival. SALL4 silencing by RNA interferen...
Сохранить в:
| Опубликовано в: : | Oncotarget |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Impact Journals LLC
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5342750/ https://ncbi.nlm.nih.gov/pubmed/27705911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12251 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|